Marshall & Sullivan Inc Gilead Sciences, Inc. Transaction History

Marshall & Sullivan Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $1.64 Million - $1.83 Million	-26,179 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$60.54 - $79.0 $3,511 - $4,582	58 Added 0.22%	26,179 $1.64 Million
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $95,515 - $105,752	1,340 Added 5.41%	26,121 $2.02 Million
Q2 2018 Jul 31, 2018	BUY	$64.88 - $75.68 $96,087 - $112,082	1,481 Added 6.36%	24,781 $0
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $48,147 - $58,696	661 Added 2.92%	23,300 $1.76 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $22,554 - $26,475	317 Added 1.42%	22,639 $1.62 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $62,014 - $73,504	860 Added 4.01%	22,322 $1.67 Million
Q2 2017 Aug 09, 2017	BUY	N/A	21,462	21,462 $1.52 Million

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Marshall & Sullivan Inc , based on Form 13F filings with the SEC.

Stay updated on Marshall & Sullivan Inc with notifications on news.